| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |